CoreCap Advisors’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.69K | Hold |
4,594
| – | – | ﹤0.01% | 1876 |
|
|
2025
Q1 | $5.61K | Sell |
4,594
-3,805
| -45% | -$4.64K | ﹤0.01% | 2056 |
|
|
2024
Q4 | $10.8K | Buy |
8,399
+704
| +9% | +$908 | ﹤0.01% | 1742 |
|
|
2024
Q3 | $21.2K | Buy |
+7,695
| New | +$21.2K | ﹤0.01% | 1532 |
|
|
2024
Q2 | – | Sell |
-7,695
| Closed | -$18.4K | – | 1975 |
|
|
2024
Q1 | $18.4K | Buy |
+7,695
| New | +$18.4K | ﹤0.01% | 1514 |
|
|
2022
Q4 | $10.4K | Buy |
+9,195
| New | +$10.4K | ﹤0.01% | 1528 |
|
|
2022
Q3 | – | Sell |
-9,195
| Closed | -$12K | – | 1108 |
|
|
2022
Q2 | $12K | Buy |
+9,195
| New | +$12K | ﹤0.01% | 1420 |
|
|
2022
Q1 | – | Sell |
-9,195
| Closed | -$19K | – | 1115 |
|
|
2021
Q4 | $19K | Buy |
+9,195
| New | +$19K | ﹤0.01% | 1345 |
|